Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NMRD Nemaura Medical Inc

0,1053

0,00 (0,00%)

10 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Nemaura Medical Charts.

Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Nemaura Medical Charts.

News Nemaura Medical Inc

Form PRE 14C - Other preliminary information statements
Freitag 19 April 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 10 April 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 26 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
Montag 22 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 9 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 9 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 3 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 3 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Important Update on Listing Status and Strategic Direction
Mittwoch 3 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 13 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere Nemaura Medical Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen